From June 10th to 12th, the 14th China Bio-Industry Conference and the 2022 Guanzhou International Bio Forum were held in Guangzhou International Bio Island, Guangdong Province. This year’s 2022 Guanzhou International Biological Forum, with the theme of “Innovative Cooperation to Build a Healthy Future”, is hosted by the Guangzhou Municipal People’s Government and undertaken by the Guangzhou Development Zone Management Committee and the Biological Island Laboratory. More than 500 experts, scholars and industry representatives in the field of biomedicine from around the world gathered in Guangzhou International Bio-Island online and offline to understand the trends of the global biopharmaceutical industry under the new situation, and jointly seek the innovation and development of the biopharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area.
The Guanzhou International Biological Forum is a high-end academic forum focusing on the innovation and development of the biological industry in Guangzhou, and it is also one of the important scientific events in the international biological science community. This forum consists of the opening ceremony, Guanzhou Life Science Roundtable Conference and Guangzhou Biomedicine and High-end Medical Device Chain Leaders Meeting, 4 professional sub-forums, conference exhibitions and other series of activities, and holds the signing ceremony of major bio-industry projects. The forum gives full play to the unique role of scientific and technological innovation in strengthening, supplementing and extending the biopharmaceutical industry chain, and provides a “good recipe” for Guangzhou to create an excellent biopharmaceutical industry ecology, leading the transformation, upgrading and prosperity of the biopharmaceutical industry and other strategic emerging industries. develop.
The project of attracting talents to expand the influence of the biomedical industry
Guangzhou International Biological Island was formerly known as “Guanzhou Island”. this.
Since 2017, when it permanently settled in Guangzhou International Biological Island, Guanzhou International Biological Forum has been successfully held for five sessions, gathering innovative resources, introducing high-end talents, attracting investment, promoting and deepening Guangzhou and domestic and foreign biological industries It has played a huge role in exchanges and cooperation, and has become a shining international business card for Guangzhou’s bio-industry.
The Guanzhou Life Science Roundtable is a brand event of the Guanzhou International Biological Forum. This year, a number of experts and heads of scientific research institutions, universities, medical institutions, entrepreneurs in the field of biomedicine, investment and financing experts gathered together to express their opinions on biosafety, life science, bioeconomy, science and technology anti-epidemic, etc., to promote the development of biotechnology in Guangzhou It is the source of original innovation in medicine and builds a new highland for the global biomedicine and health industry.
Leading by experts and scholars, it brings together high-end biomedical talents from all over the world, and activates the unique role of technological innovation in strengthening, supplementing and extending the chain of the biomedical industry. Guanzhou International Biological Forum has not only become a window for Huangpu District and Guangzhou Development Zone to display the development of the biomedical industry, but also a bridge for domestic and foreign technical exchanges and industrial connection, expanding Guangzhou’s global technological influence and industrial influence. This forum focuses on the innovation, entrepreneurship, employment environment and policy advantages of Guangzhou’s biopharmaceutical industry, attracts key projects and high-level talents to settle in Guangzhou, promotes excellent projects and innovative products of enterprises, and promotes domestic and foreign cooperation. In addition, according to the characteristics of the biopharmaceutical industry’s strong professionalism, many subdivisions, and many capital needs, the forum has set up new infectious disease vaccine innovation, traditional Chinese medicine innovation research and development and industrial development, in vitro diagnostic technology innovation and industrial development, and biomedical innovation. 4 professional sub-forums on investment and financing.
In the signing session of major bio-industry projects of this Guanzhou International Bio Forum, Guangzhou Development Zone signed contracts with 5 companies including Fangzhou Jianke, Laien Biology and Yunzhou Biology to promote a number of biomedical industry projects landing.
Ark Jianke will build a digital medical industry headquarters project in Guangzhou Development Zone; Laien Biotechnology plans to invest in the construction of a production base in Sino-Singapore Guangzhou Knowledge City as its headquarters in China; Yunzhou Biotechnology will be in Guangzhou Development Zone to build a research and development center.
Building Platforms, Proposing Practical Measures, and Optimizing Business Environment
Biomedicine is an emerging industry focused on the development of the “Trillion-Trillion Manufacturing” plan of Huangpu District and Guangzhou Development Zone during the “14th Five-Year Plan” period. Relying on 4 major strategic innovation and development platforms, namely Sino-Singapore Guangzhou Knowledge City, Guangzhou Science City, Guangzhou International Biological Island, and Huangpu Lingang Economic Zone, Huangpu District and Guangzhou Development Zone are well established in business environment, industrial layout, scientific research and innovation, etc. Prosperous land for business development, promoting the integrated development of government, production, research and medicine, and striving to build a world-class bio-innovative industrial cluster.
Huangpu District and Guangzhou Development Zone strengthen the construction of public platforms, and build a number of public platforms such as the Guangdong-Hong Kong-Macao Greater Bay Area High-performance Medical Device Innovation Center, the South China Biomaterials Entry and Exit Public Service Platform, and the Sino-Israeli Biological Industry Incubation Base The platform can fully reduce the investment cost of innovative enterprises and entrepreneurs; through the joint construction of a technical support platform for statutory inspection and testing institutions with the Guangdong Provincial Food and Drug Administration, enterprises can enjoy the high-quality services of provincial-level statutory drug inspection institutions “without leaving the area”. ; To build an industrial policy highland, and successively issued a number of special policies for the biopharmaceutical industry such as “IAB Implementation Opinions”, “8 High-end Biopharmaceuticals”, “10 Biopharmaceuticals” and “10 Traditional Chinese Medicine”, forming a multi-dimensional and full-chain policy system. , attracting many enterprises to invest and settle down.
Since 2017, a large number of biopharmaceutical enterprises have settled in Huangpu District and Guangzhou Development Zone. The number of biopharmaceutical enterprises in the district has grown from 2,000 to over 3,000 today, including 467 high-tech enterprises and listed companies. 17. At present, the revenue of the biopharmaceutical industry in Huangpu District and Guangzhou Development Zone has exceeded 170 billion yuan, ranking among the first echelons of domestic biopharmaceutical industry development.
Data source: Propaganda Department, Guangzhou Huangpu District Committee of the Communist Party of China